Clinical Trials Logo

Abscess clinical trials

View clinical trials related to Abscess.

Filter by:

NCT ID: NCT01085929 Completed - Cellulitis Clinical Trials

Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses

Start date: August 2008
Phase: Phase 3
Study type: Interventional

The incidence of skin and soft tissue infections has increased dramatically over the last decade, in part due to increased prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). Incision and drainage (I&D) is considered the primary intervention, however some clinicians prefer ultrasound guided needle aspiration (US Asp). The investigators performed a randomized trial comparing US Asp to I&D for uncomplicated skin and soft tissue abscesses, with a subgroup analysis of patients with CA-MRSA.

NCT ID: NCT01076049 Terminated - Abscess Clinical Trials

The Effect of Irrisept for Irrigation of Skin and Soft Tissue Infections (Irrisept USF Study)

Start date: January 2010
Phase: N/A
Study type: Interventional

The purpose of this study was to determine whether Irrisept can effectively prevent the progression of skin and soft tissue infections (SSTIs) as compared to treatment by the current Standard of Care.

NCT ID: NCT01045902 Completed - Clinical trials for Pneumonia, Aspiration

BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia

Start date: February 2001
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to determine the efficacy and safety of Moxifloxacin in comparison to Sulbactam/Ampicillin in the treatment of pulmonary abscesses and aspiration pneumonia.

NCT ID: NCT00984022 Completed - Cellulitis Clinical Trials

Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage

Start date: March 2008
Phase: Phase 2
Study type: Interventional

This study compares Aquacel against routine Iodoform packing for packing abscess cavities after incision and drainage. It is hypothesized that Aquacel will produce speedier healing of the abscess.

NCT ID: NCT00973765 Completed - Abscesses Clinical Trials

Prospective Randomized Trial of Bactrim on 7 Day Outcome in Patients With Uncomplicated Abscesses

Start date: November 2007
Phase: Phase 3
Study type: Interventional

Patients will be enrolled in a multi-center study to prospectively evaluate outcome after treatment for an uncomplicated skin abscess. All patients will receive incision and drainage and wound cultures. Patients will then be randomized to 1) placebo two tablets PO BID X 7 days or 2) bactrim DS (800/160) two tablets PO BID x 7 days. Patients will then return to the emergency department ED) at 48 hours and 7 for wound repacking and evaluation. The primary outcome is treatment failure rates at 7 days after incision and drainage. Patients who are clinically worsening or not improving after 48 hours will then be treated with additional antibiotics or admission if needed. Data will be analyzed both by initial randomization and intention to treat.

NCT ID: NCT00954031 Terminated - Clinical trials for Abscess, Peritonsillar

Impact of Anti-inflammatory and Antibiotic Therapy on the Emergence of Peri-tonsillar Abscess

APA
Start date: March 2009
Phase: N/A
Study type: Observational

Analyze in children and adults, risk factors in the onset of the APA. The main hypothesis focuses on the use of anti-inflammatory in the context of pharyngitis or sore throat before the symptoms of ABS. Secondary objectives: 1. - Analyze the implementation of a rapid diagnostic test and its result on the occurrence of an ABS 2. - Measure the frequency of prescription and describe the reasons for not prescribing an antibiotic for patients who consulted for a sore throat and having developed a PLA 3. - Describe the microbial flora could puncture of patients hospitalized for APA

NCT ID: NCT00925665 Completed - Odontogenic Abscess Clinical Trials

Intubation of Patients With Odontogenic Abcesses

Start date: January 2009
Phase: N/A
Study type: Observational

This study is a comparison of two techniques for endotracheal intubation (Glidescope versus Macintosh) in patients with odontogenic abscesses.

NCT ID: NCT00900510 Withdrawn - Abscess Clinical Trials

Antibiotic Therapy After Incision and Drainage for Abscess

Start date: May 2009
Phase: N/A
Study type: Interventional

Background: Skin abscesses are a growing problem in the general pediatric population around the world. While the standard treatment for an abscess/boil is incision and drainage, many physicians also prescribe antibiotics, despite the lack of evidence that antibiotics are necessary to help the wound heal. The purpose of this research study is to determine whether antibiotics are necessary after incision and drainage of a skin abscess in children. This is an important question because medical evidence has shown that using antibiotics when they are not needed has contributed to the increase of bacterial antibiotic resistance. In fact, several of the antibiotics that successfully killed Staph bacteria several years ago are now no longer effective because of antibiotic resistance. Now resistant forms of Staph bacteria, called "Community-Acquired Methicillin-Resistant Staph Aureus" (CA-MRSA), account for 50-85% of all pediatric skin abscesses. If antibiotics are not necessary then withholding them when appropriate may help slow the progression of antibiotic-resistant Staph infections. Objective(s) and Hypothesis(es): The investigators believe that antibiotics are no better than placebo at achieving a cure after drainage of an abscess in a child. The objective of this study is to answer the question: Do antibiotics after abscess drainage result in a better chance of cure than placebo? Potential Impact: If abscess drainage alone is shown to be as effective as drainage followed by antibiotics, then the routine use of antibiotics for this problem could be avoided. This would help limit the increasing antibiotic resistance of bacteria (especially CA-MRSA) in communities around the world. A well-designed study may provide the evidence to change the way children are treated for abscesses in a future where antibiotic resistant bacteria will be even more of a public health challenge.

NCT ID: NCT00895089 Completed - Liver Abscess Clinical Trials

Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess

Start date: May 2009
Phase: Phase 4
Study type: Interventional

This clinical trial compares the use of moxifloxacin versus ceftriaxone in the treatment of primary pyogenic liver abscess. The trial will include nonpregnant adults presenting with primary liver abscess based on clinical diagnosis and computed tomography. The trial aims to determine whether the use of moxifloxacin can effectively treat primary pyogenic liver abscess and shorten hospitalization. This regimen has the additional benefit of avoiding nephrotoxic agents, such as aminoglycosides, used frequently in treatment of pyogenic liver abscess. Development of antibiotic resistance to colonized bacteria in the gastrointestinal tract will also be evaluated using stool cultures.

NCT ID: NCT00867789 Terminated - Abscess Clinical Trials

Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department

Start date: March 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if there is a difference between an antibiotic, trimethoprim-sulfamethoxazole versus placebo in healing outcomes of soft tissue abscesses following incision and drainage.